Prot # RB AT PPE 01-13:Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1) ,

Project: Research project

Project Details

StatusFinished
Effective start/end date6/4/156/4/18

Funding

  • Chiltern International, Inc. (RB AT PPE 01-13)
  • rEVO Biologics, Inc. (RB AT PPE 01-13)